Booster Shots Conspiracy Theories Moderna Public Health Opinions Boosters Vaccine Development Vaccine Safety Vaccine Acceptance Coronavirus AstraZeneca Vaccine AstraZeneca Covid Vaccine Mandates Virus Strains Vaccine Research Refusal to Vaccinate Cancer Fertility Issues mRNA Technology Health Impacts mRNA Vaccines Efficacy Public Health Policy Vaccine Mandates Vaccination Rollout
The move shrinks its staff to under 5,000 by year-end to cut $1.5 billion in annual expenses by 2027.